Genomma Lab Internacional SAB de CV
BMV:LABB
Relative Value
The Relative Value of one
LABB
stock under the Base Case scenario is
hidden
MXN.
Compared to the current market price of 17.96 MXN,
Genomma Lab Internacional SAB de CV
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
LABB Competitors Multiples
Genomma Lab Internacional SAB de CV Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| MX |
|
Genomma Lab Internacional SAB de CV
BMV:LABB
|
17.5B MXN | 1 | 10.9 | 4.9 | 5.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
934.5B USD | 14.3 | 45.3 | 30.5 | 32.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.6B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
257.3B CHF | 4.2 | 19.8 | 11.7 | 13.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.5B GBP | 5.1 | 29.3 | 16.3 | 22.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
285.6B USD | 4.4 | 15.6 | 9.7 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.7 | 8 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.3B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.8 |